NASDAQ
3.78USD
-0.02 (-0.53%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
20.4M
P/E
—
EPS
—
Beta
0.75
52W range
3.19-21.4
Day range
3.73–3.82
Open
3.80
Prev close
3.80
Volume
17.7K
Avg volume
151.3K
Dividend
0.00
IPO
2021-12-16
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Neuphoria Therapeutics Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for NEUP: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
